MEDLINE Journals

    A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

    Authors

    Gorwitz RJ 

    Institution

    Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. RGorwitz@cdc.gov

    Source

    Pediatr Infect Dis J 2008 Jan; 27(1) :1-7.

    Abstract

    Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a cause of infection among otherwise healthy children and adults in the community. Skin and soft tissue infections are most common, but invasive manifestations also occur. A limited number of strains that may possess unique virulence or transmissibility factors have accounted for the majority of these infections. These strains emerged in the community but now are being transmitted in both community and healthcare settings. Incision and drainage remains the primary treatment for skin abscesses. Strains of MRSA circulating in the community generally are susceptible to a number of nonbeta-lactam antimicrobial agents, although resistance patterns may vary temporally and geographically. Educating patients on strategies to prevent further transmission is a critical component of case management. More data are needed to determine optimal strategies for management and prevention of MRSA skin infections in the community.

    Mesh

    Adult
    Child
    Community-Acquired Infections
    Humans
    Methicillin Resistance
    Soft Tissue Infections
    Staphylococcal Skin Infections
    Staphylococcus aureus

    Language

    eng

    Pub Type(s)

    Journal Article Review

    PubMed ID

    18162929

    Content Manager
    Related Content

    Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections.

    Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.

    Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections.

    Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

    The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

    Community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus: skin and soft tissue infections in Hong Kong.

    Community-associated methicillin-resistant staphylococcal infection in an inner city hospital pediatric inpatient population.

    Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections.